T1D-Plus trial glucose monitors for Cardiff University come from Dexcom
- Cardiff University
- Wales
- Direct
- 20 January 2026 to 20 January 2027
Cardiff University is buying continuous glucose monitoring devices from Dexcom for T1D-Plus, a trial in adults newly diagnosed with type 1 diabetes.
The university sponsors the randomised platform trial, which runs across several centres. Funded by JDRF, it began on 30 September 2022. The Helmsley Charitable Trust and JDRF Australia have since funded extra arms through their own grants. Glucose readings from a monitoring device are one of the trial's endpoints, and the devices on the market vary in specification.
The university awarded the £76,000 contract directly. It runs from January 2026 to January 2027.
Contract ends January 2027
- What
- Diabetes devices and glucose monitoring supplies
- Buyer
- Cardiff University
- Supplier
- Dexcom
- Value
- £76,000
- How it was bought
- Direct
- Dates and next
- Jan 2026 to Jan 2027